Hydromorphone is an opioid analgesic used to treat moderate to severe pain when the use of an opioid is indicated.
Topic |
|---|
|
|
| All by date | | | Start date | Site | Title |
|---|
| ML25211A304 | 30 July 2025 | | OIG-DNFSB-25-A-03: Audit of the Defense Nuclear Facilities Safety Board’S Drug-Free Workplace Program, Dated July 30, 2025 | | ML25148A130 | 5 June 2025 | | NRC Fitness for Duty Program Updates-NEI Access Authorization Fitness for Duty Workshop June 2025 | | ML24334A032 | 3 December 2024 | | Presentation to the Drug Testing Advisory Board on NRC 10 CFR Part 26 Fitness for Duty Program, December 3, 2024 | | ML24152A229 | 29 October 2024 | | IP 81000.08 Fitness-for-Duty | | ML24295A361 | 25 September 2024 | Erwin | Nuclear Fuel Services, Inc (NFS) - 30-Day Written Notification of Event (NRC Event No. 57296) | | NL-24-0349, Units 1 and 2 - 10 CFR 26.719(c)(1) 30-Day Report Blind Performance Test Results Inconsistent with Sample Provided | 20 September 2024 | Farley | Units 1 and 2 - 10 CFR 26.719(c)(1) 30-Day Report Blind Performance Test Results Inconsistent with Sample Provided | | ENS 57291 | 26 August 2024 17:00:00 | Farley | False Negative Indicated on a Fitness for Duty Blind Quality Assurance Test | | ML24185A212 | 11 July 2024 | | 10 CFR Part 26 Fitness for Duty Program Updates, NEI Access Authorization-Fitness for Duty Workshop July 2024 | | ML24152A151 | 4 June 2024 | | Presentation to the Drug Testing Advisory Board (Hhs/Samhsa), Performance Trends and Program Updates, Fitness for Duty (FFD) Programs, 10 CFR Part 26, June 4, 2024 - Slides | | ML24116A143 | 7 February 2024 | | NRC Public Meeting Transcript, February 7, 2024 - 10 CFR Part 26 Technical Issues Rulemaking |
|
|---|